Publikationen, an denen er mitarbeitet Jesús María Prieto Valtueña (26)

2019

  1. Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses

    Molecular Therapy, Vol. 27, Núm. 11, pp. 1892-1905

2016

  1. Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 20, pp. 3897-3916

2014

  1. A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system

    Cellular and Molecular Life Sciences, Vol. 71, Núm. 23, pp. 4637-4651

  2. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas

    Human Gene Therapy, Vol. 25, Núm. 2, pp. 132-143

2013

  1. Eradication of liver-implanted tumors by semliki forest virus expressing IL-12 requires efficient long-term immune responses

    Journal of Immunology, Vol. 190, Núm. 6, pp. 2994-3004

  2. Prognostic factors and prevention of radioembolization-induced liver disease

    Hepatology, Vol. 57, Núm. 3, pp. 1078-1087

2012

  1. A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumors

    Gene Therapy, Vol. 19, Núm. 3, pp. 271-278

2010

  1. A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vector

    New Biotechnology, Vol. 27, Núm. 2, pp. 138-148

  2. Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates

    Molecular Therapy, Vol. 18, Núm. 4, pp. 754-765

2009

  1. Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma

    Journal of Virology, Vol. 83, Núm. 23, pp. 12266-12278

2008

  1. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability

    Virology, Vol. 376, Núm. 1, pp. 242-251

  2. Transcriptomic effects of Tet-on and mifepristone-inducible systems in mouse liver

    Human Gene Therapy, Vol. 19, Núm. 11, pp. 1233-1247

2007

  1. Biodistribution and tumor infectivity of Semliki Forest virus vectors in mice: Effects of re-administration

    Molecular Therapy, Vol. 15, Núm. 12, pp. 2164-2171

  2. Reactive oxygen species (ROS) mediate the effects of leucine on translation regulation and type I collagen production in hepatic stellate cells

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1773, Núm. 11, pp. 1681-1688

2006

  1. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector

    Cancer Research, Vol. 66, Núm. 3, pp. 1620-1629

  2. Leucine stimulates procollagen α1(I) translation on hepatic stellate cells through ERK and PI3K/Akt/mTOR activation

    Journal of Cellular Physiology, Vol. 209, Núm. 2, pp. 580-586

  3. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 66, Núm. 3, pp. 792-800

2005

  1. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas

    Journal of Clinical Oncology, Vol. 23, Núm. 5, pp. 999-1010

  2. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas

    Molecular Therapy, Vol. 12, Núm. 1, pp. 153-163

2003

  1. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis

    Gastroenterology, Vol. 124, Núm. 4, pp. 1037-1042